Modification of Antitumor Disulfide Cytotoxicity by Glutathione Depletion in Murine Cells

Cancer Research

Volumn 47, Issue 16, 1987, Pages 4391-4395

  Kirkoatrick, D Lynn ^a  

^a UNIVERSITY OF REGINA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

6 MERCAPTOPURINE DERIVATIVE; ANTINEOPLASTIC AGENT; BUTHIONINE SULFOXIMINE; GLUTATHIONE; NEW DRUG; THIOGUANINE DERIVATIVE; THIOPHENOL;

ANIMAL CELL; CANCER CHEMOTHERAPY; CELL CULTURE; CYTOTOXICITY; DRUG CYTOTOXICITY; DRUG POTENTIATION; HYPOXIA; IN VITRO STUDY; INTOXICATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; THERAPY;

6-MERCAPTOPURINE; ANIMAL; ANTINEOPLASTIC AGENTS; BUTHIONINE SULFOXIMINE; CELLS, CULTURED; DISULFIDES; GLUTATHIONE; METHIONINE SULFOXIMINE; MICE; OXYGEN; SULFHYDRYL COMPOUNDS; SUPPORT, NON-U.S. GOV'T; THIOGUANINE;

EID: 0023195011     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Kennedy, K. A., Teicher, B. A., Rockwell, S., and Sartorelli, A. C. The Hypoxic Tumor Cell: A Target for Selective Cancer Chemotherapy. Biochem. Pharmacol., 29:1-8, 1980.
2. Kennedy, K. A., Teicher, B. A., Rockwell, S., and Sartorelli, A. C. Chemotherapeutic Approaches to Cell Populations of Tumors. In: A. C. Sartorelli, J. S. Laso, and J. R. Bertino (eds.), Molecular Actions and Targets for Cancer Chemotherapeutic Agents, pp. 85–101. New York: Academic Press, 1981.
3. Lin, A. J., Cosby, L. A., Shansky, C. W., and Sartorelli, A. C. Potential Bioreductive Alkylating Agents. 1. Benzoquinone Derivatives. J. Med. Chem., 15: 1247–1252, 1972.
4. Lin, A. J., Shansky, C. W., and Sartorelli, A. C. Potential Bioreductive Alkylating Agents. 3. Synthesis and Antineoplastic Activity of Acetoxymethyl and Corresponding Ethyl Carbamate Derivatives of Benzoquinones. J. Med. Chem., 17: 558–561, 1974.
5. Lin, A. J., Lillis, B. J., and Sartorelli, A. C. Potential Bioreductive Alkylating Agents. 5. Antineoplastic Activity of Quinoline-5,8-diones, Naphthazarins and Naphthoquinones. J. Med. Chem., 18:917-921, 1975.
6. Lin, T-S., Teicher, B. A., and Sartorelli, A. C. 2-Methylanthraquinone Derivatives as Potential Bioreductive Alkylating Agents. J. Med. Chem., 23: 1237–1242, 1980.
7. Witiak, D. T., Kamat, P. L., Allison, D. L., Liebowitz, S. M., Glaser, R., Holliday, J. E., Moeschberger, M. L., and Schaller, J. P. Bis(bioreductive) Alkylating Agents: Synthesis and Biological Activity in a Nude Mouse Human Carcinoma Model. J. Med. Chem., 26:1679-1686, 1983.
8. Rockwell, S., Kennedy, K. A., and Sartorelli, A. C. Mitomycin-C as a Prototype Bioreductive Alkylating Agent: In vitro Studies of Metabolism and Cytotoxicity. Int. J. Radiat. Oncol. Biol. Phys., 8:753-755, 1982.
9. Mohindra, J. K., and Rauth, A. M. Increased Cell Killing by Metronidazole and Nitrofurazone of Hypoxic Compared to Aerobic Mammalian cells. Cancer Res., 36:930-936, 1976.
10. Sutherland, R. M. Selective Chemotherapy of Noncycling Cells in an in vitro Tumor Model. Cancer Res., 34:3501-3503, 1974.
11. Martinez, J., Oiry, J., Imbach, J. L., and Winternitz, F. Activated N-Nitrosocarbamates for Regioselective Synthesis of Nitrosoureas. J. Med. Chem., 25:178-182, 1982.
12. Lown, J. W. Synthesis and Properties of New Antileukemic 2-Haloethylnitrosoureas Based on an Analysis of Their Reactions with DNA. In: T. J. Bardos and T. I. Kalman (eds.), New Approaches to the Design of Antineoplastic Agents, pp. 61–93. New York: Elsevier Biomedical, 1982.
13. Saneyoshi, M., Inomata, M., Sekine, T., Hoshi, A., and Fukuoka, F. Synthetic Nucleosides and Nucleotides. X. Synthesis and Biological Activities of Several Purin-6-yl Benzyl Disulfides and Their Ribonucleosides. J. Pharm. Dyn., 1:168-174, 1978.
14. Inomata, M., Fukuoka, F., Hoshi, A., Kuretani, K., and Saneyoshi, M. Antitumor Activity of Alkyldisulfide Derivates of 6-Mercaptopurines Against L-1210 Leukemia. J. Pharm. Dyn., 4:928-932, 1981.
15. Mannervik, B., Guthenberg, C., Jensson, H., Warholm, M., and Alin, P. Isozymes of Glutathione S-Transferases in Rat and Human Tissues. In: A. Larsson, S. Orrenius, A. Holmgren, and B. Mannervik (eds.), Functions of Glutathione-Biochemical, Physiological, Toxicological and Clinical Aspects, pp. 75–88. New York: Raven Press, 1983.
16. Biaglow, J. E., Varnes, M. E., Roizen-Towle, L., Clark, E. P., Epp, E. R., Astor, M. B., and Hall, E. J. Biochemistry of Reduction of Nitro Heterocycles. Biochem. Pharmacol., 35:77-90, 1986.
17. Hodgkiss, R. J., and Middleton, R. W. Effects of Glutathione Depletion Using Buthionine Sulfoximine on the Cytotoxicity of Nitroaromatic Compounds in Mammalian Cells in vitro. Biochem. Pharmacol., 34:2175-2178, 1985.
18. Bump, E. A., Yu, N. Y., and Brown, J. M. Radiosensitization of Hypoxic Tumor Cells by Depletion of Intracellular Glutathione. Science (Wash. DC) 217: 544–545, 1982.
19. Clark, E. P., Epp, E. R. Biaglow, J. E., Morse-Guadio, M., and Zachgo, E. Glutathione Depletion, Radiosensitization and Mesonidazole Potentiation in Hypoxic Chinese Hamster Ovary Cells by Buthionine Sulfoximine. Radiat. Res., 98:370-380, 1984.
20. Russo, A., and Mitchell, J. B. Potentiation and Protection of Adriamycin Cytotoxicity by Glutathione Modulation. Cancer Treat. Rep., 69: 1293–1296, 1985.
21. Hamilton, T. C., Winker, M. A., Louie, K. G., Batist, G., Behrens, B. C., Tsuruo, T., Grotzinger, K. R., McKoy, W. M., Young, R. C., and Ozols, R. F. Augmentation of Adriamycin, Melphalan and Cisplatin Cytotoxicity in Drug-Resistant and -Sensitive Human Ovarian Carcinoma Cell Lines by Buthionine Sulfoximine Mediated Glutathione Depletion. Biochem. Pharmacol., 34:2583-2586, 1985.
22. Green, J. A., Vistica, D. T., Young, R. C., Hamilton, T. C., Rogan, A. M., and Ozols, R. F. Potentiation of Melphalan Cytotoxicity in Human Ovarian Cancer Cell Lines by Glutathione Depletion. Cancer Res., 44: 5427–5431, 1984.
23. Russo, A., DeGraff, W., Friedman, N., and Mitchell, J. B. Selective Modulation of Glutathione Levels in Human Normal Versus Tumor Cells and Subsequent Differential Response to Chemotherapy Drugs. Cancer Res., 46: 2845–2848, 1986.
24. Griffith, O. W., and Meister, A. Inhibition of Glutathione Synthesis by Buthionine Sulfoximine (S-(n-Butyl)Homocysteine Sulfoximine). J. Biol. Chem., 254:7558-7560, 1979.
25. Sirakawa, K., Aki, O., Tsujikawa, T., and Tsuda, T. S-Alkylthioisothioureas. I. Chem. Pharm. Bull., 18:235-242, 1970.
26. Rockwell, S. In vivo-in vitro Tumor Systems: New Models for Studying the Response of Tumors to Therapy. Lab. Anim. Sci., 27:831-851, 1977.
27. Kennedy, K. A., Rockwell, S., and Sartorelli, A. C. Preferential Activation of Mitomycin C to Cytotoxic Metabolites by Hypoxic Tumor Cells. Cancer Res., 40:2356-2360, 1980.
28. Tietze, F. Enzymatic Method for Quantitative Determination of Nanogram Amounts of Total and Oxidized Glutathione. Application to Mammalian Blood and Other Tissues. Anal. Biochem., 27:502-522, 1969.
29. Elion, G., Callahan, S., Rundles, W., and Hitchings, G. Relationship Between Metabolic Fates and Antitumor Activities of Thiopurines. Cancer Res., 23: 1207-1217, 1963.
30. Clarke, D. A., Elion, G. B., Hitchings, G. H., and Stock, E. C. Structure-activity Relationships Among Purines Related to 6-Mercaptopurine. Cancer Res., 18:445-456, 1959.
31. Skipper, H. E., Montgomery, J. A., Thomson, J. R., and Schabel, F. M. Structure-activity Relationships and Cross-resistance Observed on Evaluation of a Series of Purine Analogs Against Experimental Neoplasms. Cancer Res., 19:425-437, 1959.
32. Elion, G. B., Callahan, S. W., Hitchings, G. H., Rundles, R. W., and Laszlo, J. Experimental, Clinical and Metabolic Studies of Thiopurines. Cancer Chemother. Rep., 16:197-202, 1962.
33. Meredith, M. J., and Reed, D. J. Status of the Mitochondrial Pool of Glutathione in the Isolated Hepatocyte. J. Biol. Chem., 257: 3747–3753, 1982.
34. Reed, D. J., Brodie, A. E., and Meredith, M. J. Cellular Heterogeneity in the Status and Functions of Cysteine and Glutathione. In: A. Larsson, S. Orrenius, A. Holmgren, and B. Mannervik (eds.), Functions of Glutathione Biochemical, Physiological, Toxicological, and Clinical Aspects, pp. 39–49. New York: Raven Press, 1983.
35. Moldéus, P., and Jemström, B. Interaction of Glutathione with Reactive Intermediates. In: A. Larsson, S. Orrenius, A. Holmgren, and B. Mannervik (eds.), Functions of Glutathione Biochemical, Physiological, Toxicological, and Clinical Aspects, pp. 99–108. New York: Raven Press, 1983.
36. Bump, E. A., Taylor, Y. C., and Brown, J. M. Role of Glutathione in the Hypoxic Cell Cytotoxicity of Misonidaizole. Cancer Res., 43: 997–1002, 1983.
37. Rojas, A., Smith, K. A., Soranson, J. A., Minchinton, A. I., Middleton, R. W., and Denekamp, J. Enhancement of Misonidazole Radiosensitization by Buthionine Sulfoximine. Radiother. Oncol., 2:325-332, 1984.
38. Minchinton, A. I., Rojas, A., Smith, K. A., Soranson, J. A., Shrieve, D. C., Jones, N. R., and Bremner, J. C. Glutathione Depletion in Tissues After Administration of Buthionine Sulphoximine. Int. J. Radiat. Oncol. Biol. Phys., 10:1261-1264, 1984.